Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Total knee arthroplasty in an adult with congenital dislocation of the patella.
Risk assessment for inpatient survival in the long-term acute care setting after prolonged critical illness.
Is there an omitted stimulus response in the human cone flicker electroretinogram?
Minimal residual disease in acute myeloid leukemia--current status and future perspectives.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Minimal residual disease in acute myeloid leukemia--current status and future perspectives.
Minimal residual disease in acute myeloid leukemia--current status and future perspectives. Curr Hematol Malig Rep. 2015 Jun; 10(2):132-44.
View in:
PubMed
subject areas
Biomarkers, Tumor
DNA Mutational Analysis
Flow Cytometry
High-Throughput Nucleotide Sequencing
Humans
Leukemia, Myeloid, Acute
Neoplasm, Residual
Predictive Value of Tests
Prognosis
Real-Time Polymerase Chain Reaction
Remission Induction
authors with profiles
Wendy Stock